CDIO
CDIO
NASDAQ · Biotechnology

Cardio Diagnostics Holdings

$1.89
+0.02 (+1.07%)
As of Nov 14, 2:53 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,647.6% upside
Low Target $21.42
Average Target $33.03
High Target $37.66
Current Price $1.89
Current
$1.89
Target
$33.03
$21.42 $33.03 avg $37.66
Scenario Analysis
Bear Case
$21.42
1,033.3%
Low target
Base Case
$33.03
+1,647.6%
Avg target
Bull Case
$37.66
+1,892.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$7.91
-76.1% from high
52-Week Low
$0.97
+94.8% from low
Target vs 52W High
$33.03
+317.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%